We are live on
!
Find out more
GCM
Geneva Capital Management Portfolio holdings
AUM
$4.36B
1-Year Est. Return
17.81%
This Fund
S&P 500
This Quarter
Est. Return
+4.77%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
–
AUM
$5.86B
AUM Growth
-$42.8M
(-0.72%)
Cap. Flow
-$217M
Cap. Flow
% of AUM
-3.71%
Top 10 Holdings %
Top 10 Hldgs %
20.97%
Holding
130
New
5
Increased
19
Reduced
104
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioLife Solutions
BLFS
|
+$40.8M |
| 2 |
QADA
QAD Inc.
QADA
|
+$28.1M |
| 3 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$25.1M |
| 4 |
Onto Innovation
ONTO
|
+$24.2M |
| 5 |
Globus Medical
GMED
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IPHI
INPHI CORPORATION
IPHI
|
+$68.7M |
| 2 |
RP
RealPage, Inc.
RP
|
+$44.7M |
| 3 |
CMD
Cantel Medical Corporation
CMD
|
+$40.2M |
| 4 |
Monolithic Power Systems
MPWR
|
+$37.8M |
| 5 |
STAAR Surgical
STAA
|
+$34.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.72% |
| 2 | Industrials | 22.87% |
| 3 | Healthcare | 20.34% |
| 4 | Consumer Discretionary | 9.47% |
| 5 | Financials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Mercury Systems
MRCY
$6.52B
| $16.1M | 0.28% |
+228,205
| New | +$16.5M |
|
102
Cognex
CGNX
$11.3B
| $15.6M | 0.27% |
188,217
-10,139
| -5% | -$845K |
|
103
HEICO Corp Class A
HEI.A
$37.2B
| $15.5M | 0.26% |
136,367
+35,925
| +36% | +$4.18M |
|
104
JB Hunt Transport Services
JBHT
$25.2B
| $14.7M | 0.25% |
87,741
-4,504
| -5% | -$678K |
|
105
Etsy
ETSY
$7.85B
| $14.4M | 0.25% |
71,354
-3,970
| -5% | -$831K |
|
106
Cooper Companies
COO
$14.5B
| $14.3M | 0.24% |
148,912
-8,096
| -5% | -$768K |
|
107
Fortune Brands Innovations
FBIN
$6.06B
| $12.8M | 0.22% |
156,056
-7,519
| -5% | -$569K |
|
108
Microsoft
MSFT
$3.71T
| $4.54M | 0.08% |
19,242
-182
| -0.9% | -$42.2K |
|
109
Danaher
DHR
$144B
| $4.51M | 0.08% |
22,601
-220
| -1% | -$44.7K |
|
110
Alphabet (Google) Class A
GOOGL
$4.33T
| $4.49M | 0.08% |
43,500
-5,840
| -12% | -$576K |
|
111
Paycom
PAYC
$9.69B
| $4.39M | 0.07% |
11,863
-27
| -0.2% | -$10.6K |
|
112
Lowe's Companies
LOW
$125B
| $4.23M | 0.07% |
22,265
-213
| -0.9% | -$36.5K |
|
113
Adobe
ADBE
$105B
| $4.22M | 0.07% |
8,879
-89
| -1% | -$41.6K |
|
114
Thermo Fisher Scientific
TMO
$220B
| $4.05M | 0.07% |
8,881
-91
| -1% | -$43.4K |
|
115
Visa
V
$677B
| $3.69M | 0.06% |
17,420
-161
| -0.9% | -$33.9K |
|
|
ATVI
116
DELISTED
Activision Blizzard
ATVI
| $3.54M | 0.06% |
38,069
-376
| -1% | -$35.3K |
|
|
IPHI
117
DELISTED
INPHI CORPORATION
IPHI
| $3.44M | 0.06% |
19,277
-411,300
| -96% | -$68.7M |
|
118
Costco
COST
$420B
| $3.38M | 0.06% |
9,594
+1,248
| +15% | +$434K |
|
119
Edwards Lifesciences
EW
$51.7B
| $3.24M | 0.06% |
38,699
+4,529
| +13% | +$383K |
|
120
TJX Companies
TJX
$178B
| $3.15M | 0.05% |
47,624
-458
| -1% | -$30.7K |
|
121
Salesforce
CRM
$158B
| $3.06M | 0.05% |
14,446
-129
| -0.9% | -$28.7K |
|
122
Ecolab
ECL
$79.9B
| $2.67M | 0.05% |
12,480
-126
| -1% | -$26.8K |
|
123
iShares Russell 2000 Growth ETF
IWO
$15B
| $2.52M | 0.04% |
8,368
-6,396
| -43% | -$1.99M |
|
124
Walt Disney
DIS
$181B
| $2.13M | 0.04% |
11,563
-102
| -0.9% | -$18.8K |
|
125
VF Corp
VFC
$5.89B
| $2.03M | 0.03% |
25,414
-238
| -0.9% | -$19.3K |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CFO
Geneva Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Geneva Capital Management held 130 positions worth $5.86B, down 0.72% from $5.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Capital Management withdrew a net $217M in Q1 2021, closing 2 positions and reducing 104 holdings. Its most notable exit was RealPage, Inc., an estimated $44.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Geneva Capital Management opened a new position in BioLife Solutions worth $37.2M.
- Geneva Capital Management's largest Q1 2021 buy was BioLife Solutions: 1,033,095 shares worth $37.2M.
- Geneva Capital Management added most to QAD Inc. in Q1 2021, an estimated $28.1M increase.
- Geneva Capital Management's biggest Q1 2021 reduction was INPHI CORPORATION, cutting an estimated $68.7M.
- Geneva Capital Management fully exited RealPage, Inc. in Q1 2021, selling an estimated $44.7M.
- Geneva Capital Management's ten largest holdings make up 21% of its $5.86B portfolio in Q1 2021.
- Geneva Capital Management opened 5 new positions and closed 2 in Q1 2021.
- Geneva Capital Management's portfolio value fell 0.72% quarter-over-quarter to $5.86B.
Based on Geneva Capital Management's 13F filing for Q1 2021, filed 3 May 2021.